sclerosis lesions, but we assume that smooth muscle cell growth and vascular remodeling, as the response to growth factors and inflammatory cytokines, is the basic biological response to vascular tissue inflammation. As long as KD vasculitis and atherosclerosis are based on an inflammatory reaction, there should be pathophysiological and genetic similarities as well as differences. We suspect that similar inflammatory reactions may facilitate the post-KD coronary artery in making atherosclerotic lesions. We hypothesize that vascular senescence has already appeared in the KDaffected vasculature and might contribute to future atherosclerosis. Typical vascular senescence findings are increase of -galactosidase ( -gal) activity, as well as a decrease of the vascular physiological protein eNOS. 9 In addition, increased adhesive proteins, such as vascular adhesion molecule-1 (VCAM-1), 6 as well as increased chemokines, such as chemokine monocyte chemoattractant protein-1 (MCP-1), 12, 13 are major vascular histological findings in the atherosclerosis lesion. In the present study we examined whether these histological characteristics might have already appeared in the KD aneurysm, and whether gene expression profiling by cDNA microarray might show what is proceeding in KD aneurysm. This study is the first to analyze the KD aneurysm from the standpoint of vascular senescence.
Preparation of Coronary Artery Tissues
Five patients (age: 7.4±1.7 years) with KD who had giant coronary aneurysms underwent coronary artery bypass grafting (CABG) because of myocardial ischemia induced by coronary artery stenosis. The mean time from KD onset to CABG was 3.7±1.6 years. These patients also had aneurysm size-reduction procedures (plication) as an adjunct operation (Table 1 ) and so our specimens were from the center of the giant aneurysms. We conducted this procedure when the patients underwent CABG, in addition, thrombus formation was uncontrollable, even with warfarin anticoagulation therapy, because of the size of the aneurysms. 14 Shear stress to the vascular wall is inversely proportional to vascular radius, so an increase in shear stress was expected Table. with reduction of the radius of the aneurysm. It was also anticipated that turbulent flow in the aneurysm would become pulsatile and that coronary flow velocity would be increased. 15 Reducing the vascular radius and increasing the flow velocity both contribute to augmentation of vascular shear stress and this protects against thrombus formation in the aneurysm. 16 Therefore, we expected that the plication procedure would greatly assist the anticoagulation therapy. The excised coronary arteries were the subject of our analysis and the internal thoracic arteries (ITA), trimmed for CABG, were used as controls. This study was approved by the Nippon Medical School Ethics Committee and written informed consent was given by the patients' parents.
Senescence-Associated -Gal Activity
Senescence-associated -gal activity was examined in the tissues as described previously. 9 Briefly, the samples were fixed in 4% paraformaldehyde (PFA) for 30 min at room temperature and incubated for 24 h at 37°C in freshly prepared -gal staining solution containing 1 mg/ml 5-bromo-4-chrolo-3-indlyl -D-galactopylanoside (X-gal), 5 mmol/L potassium ferrocyanide, 5 mmol/L potassium fericyanide, 150 mmol/L NaCl, 2 mmol/L MgCl2, 0.01% sodium deoxycholate, and 0.02% Nonidet-40. After the stained arteries were photographed, the samples were immersed in OCT compound (Sakura Finetechnical Co Ltd, Tokyo, Japan) and frozen in dry ice prior to cryostat sectioning.
cDNA Microarray Gene Expression Profiling
Excised arterial tissue was immersed immediately in RNAlater stabilization reagent (QIAGEN Science, MD, USA), and the RNA was extracted using the RNeasy mini kit (QIAGEN Science). Contaminating DNA was removed using an RNase-free DNase kit (QIAGEN Science). Total RNA was treated as the starting material for cDNA microarray analysis (Human ATLAS 1.2, BD Bioscience Clontech, Palo Alto, CA, USA) following the manufacturer's protocol. Briefly, a probe was synthesized from over 3 g of the total RNA and dATP-P 32 , and was hybridized overnight at 68°C to the micro-array membranes. Thereafter, the membranes were washed several times and exposed to X-ray film for up to 1 week. The X-ray films were scanned (ES-2000 EPSON) and the data were analyzed using ATLAS Image 1.5 software (BD Bioscience Clontech). The gene expression signal of each of the 5 membranes per tissue sample (5 ITA samples, 5 coronary artery aneurysm samples) was averaged by the software, and compared. We defined Array1 as the ITA, and Array2 was as the aneurysm. The ratio and difference in the signals were calculated as follows: ratio = (signal intensity from Array2 (A2))/(signal intensity from Array1 (A1)), difference = (A2) -(A1). When the ratio was over 1.5 (or below 0.67), and the difference was over/under 1,000, gene expression difference was considered prevalent (Table 2) .
Quantitative Polymerase Chain Reaction (PCR) for MCP-1 Expression
The primers and probe for MCP-1 were designed according to the cDNA sequence (Gene Bank S69738) using Primer Express software (Applied Biosystems, Foster City, CA, USA). Forward primer: 5'CGCCTCCAGCATGAAA-GTCT3'; reverse primer: 5'GGGAATGAAGGTGGCTG-CTA3', and Probe 5'-(6-Fam)-CGCCCTTCTGTGCCTG-CTGCT-(Tamra) (Phospate)-3'. The -actin primers and probe were purchased from Applied Biosystems. The RNA obtained from the aneurysm and ITA was reverse transcribed using a reverse transcription PCR (RT-PCR) kit (Takara Bio Inc, Ohtsu, Japan). Quantitative PCR for MCP-1 was performed with the GeneAmp 5700 Sequence Detection System (Applied Biosystems). The amounts of -actin were simultaneously measured and the ratio of MCP-1 to -actin was calculated. The data are expressed as mean ± SE. MCP-1 expression was compared between the aneurysm and ITA samples by Student's t-test using StatView 5.0 (SAS Institute Inc Cary, NC, USA).
Immunohistochemistry
The excised tissue samples were fixed in 4% PFA, embedded in paraffin, and sliced into 4-m sections. Following de-paraffinization and heat antigen retrieval, the primary antibodies were loaded after intrinsic peroxidase blocking. Working dilutions of the primary antibodies were as follows: anti-CD31 (1:50, clone JC70A, Dako Cytomation, Location, Glostrup, Denmark), anti-eNOS (1:75, clone 3, BD Biosciences Pharmigen, San Jose, CA, USA), anti-VCAM-1 (1:50, H-276, Santa Cruz Biotechnology Inc Santa Cruz, CA, USA) and anti-MCP-1 (1:10, ab7814, Abcam, Cambridge, UK). Antibody signals were detected by a (C) Frozen cross-section of -gal-stained KD aneurysm: the blue color is mainly localized inside the aneurysm, suggesting that -gal activity is mainly by endothelial cells (long arrows). Beta-gal activity is also observed on the adventitial side of the KD aneurysm (short arrows), suggesting senescence changes are also occurring at this location. KD, Kawasaki disease; ITA, internal thoracic artery.
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Dako envision/HRP kit. Peroxidase activity was visualized by 0.02% 3-3' diaminobenzidine and 0.05% hydrogen peroxide (Dako Cytomation).
Results

Senescence-Associated -Gal Activity Staining
Beta-gal activity was hardly detected in the ITA samples (Fig 1A) , but in the aneurysm samples there was strong activity on both the intimal surface (Fig 1B) , corresponding to the vascular endothelium, and on the adventitia (Fig 1C) .
cDNA Microarray Gene Expression Profiling
The gene expression differences between the aneurysm and ITA samples are shown in Table 2 . The genes that were significantly expressed in the aneurysm samples were procollagen 2 (IV) subunit precursor, metalloproteinase inhibitor 1 precursor (TIMP1), MCP-1, matrix metalloproteinase 11 (MMP11), and apoptotic protease activating factor 1 (APAF1). 
MCP-1 Quantitative PCR
MCP-1 expression was significantly increased in the aneurysm samples compared with the ITA samples (Fig 2) . The -actin/MCP-1 ratio was 1.25±0.05 for aneurysm tissue and 1.11±0.09 for ITA tissue, which was a significant difference (p=0.015).
Immunohistochemistry
CD31 was stained in the endothelium of both ITA and aneurysm samples (Figs 3A,B) . In addition, CD31 was present in the vasa vasorum of the aneurysm (Fig 3B2) .
In the control ITA, eNOS was detected along the vascular endothelium (Fig 4A) , but was hardly detected on the endothelial surface of the aneurysm samples (Fig 4B) . In contrast, eNOS was highly expressed in the vasa vasorum in the aneurysms (Fig 4B) .
None to minuscule VCAM-1 staining was observed in the ITA (Fig 5A) , but the endothelium of the intimal surface of the aneurysm (Fig 5B1) , and of the vasa vasorum, was well stained with VCAM-1 (Fig 5B2) .
None to minuscule MCP-1 staining was observed in the ITA (Fig 6A) , but was detected in the vasa vasorum of the aneurysms (Fig 6B2) , although not in the intimal endothelium (Fig 6B1) .
Discussion
The histological features of KD coronary lesions are destruction of the 3 layers of vessel walls and significant intimal hyperplasia, 17 and to date KD has been considered as a specific vasculitis of children only. Recent immunohistological studies suggest that KD coronary artery lesions are not silent terminal tissue after vasculitis. They actively produce inflammatory cytokines 18 and were still in the active remodeling state. 11 In the present study we also confirmed high expression of genes associated with vascular remodeling, such as procollagen 2, TIMP1, MCP-1, MMP11, and APAF1, in the KD aneurysm, suggesting active remodeling was taking place. Furthermore, we detected increased senescence-associated -gal activity in the adventitia and the luminal surface of the endothelium. Both MCP-1 and VCAM-1 were strongly expressed in the vasa vasorum of the adventitia. Miura et al 19 also reported expression of cell adhesion molecules, including VCAM-1, in the neovasculature of KD coronary arteries. All of these findings suggest that the KD aneurysm is not terminal silent debris after severe vasculitis. High expression of extracellular matrix, such as procollagen , may facilitate vascular stiffness or vascular sclerosis. Intriguingly, VCAM-1 and MCP-1 were mainly expressed in the vasa vasorum of the KD aneurysm, which we consider is a histological finding that is unique to KD and different from that of adult atherosclerosis lesions, and that it suggests a distinct disease progression. Although adult atherosclerosis progression originates from the intimal side of the arteries, the sclerotic change of the KD aneurysm may develop from the adventitial vasa vasorum. We propose that vascular disease progression in KD differs from that of adult atherosclerosis.
Not only are there differences, but there are also similarities between adult atherosclerosis and the KD aneurysm. One of the characteristic histological features in atherosclerosis is "vascular senescence", which includes a decrease in vasodilative factors, such as nitric oxide, and an increase in vascular wall stiffness, cell adhesion molecules, and inflammatory cytokines. 10 Vascular senescence is closely related to atherosclerosis. 10 This study is the first to demonstrate that vascular senescence is developing in the KD aneurysm. The intimal surface of the KD aneurysmal endothelium is often denuded in acute phase KD vasculitis, 19 but we found that endothelial cells, as detected by positive CD31 staining, had regrown on the intimal surface of the late-stage KD aneurysm. However, the intimal side of the endothelium showed a decreased expression level of physiological proteins such as eNOS and increased levels of adhesion molecules such as VCAM-1, the latter being closely related to atherosclerosis. 6 These findings, typical of histological senescence, are surely a sign of disease progression in the KD aneurysm, and lead to the suspicion of early atherosclerosis developing in a KD aneurysm.
However, it is ridiculous to think that vascular senescence is a specific finding only for atherosclerosis. Because atherosclerosis is one of the vascular inflammatory diseases, [5] [6] [7] it is natural to think that the inflammatory reaction itself facilitates vascular senescence. The pro-inflammatory factors, such as chemokines, cytokines, inflammatory cells, vascular blood flow, and shear stress, are all important background mechanisms for vascular senescence. Therefore, we think it is no wonder that the KD aneurysm showed vascular senescence.
In this study, we examined the gene expression profiling of KD aneurysm tissue, and found a high expression of MCP-1, which was also confirmed by quantitative PCR. MCP-1 directs monocytes to the intima and plays a central role in the development of atherosclerotic plaques. 20 Several lines of evidence suggest that MCP-1 and its receptor CCR2 are involved in atherosclerosis. 12, 21 The MCP-1 gene polymorphism -2578G, which correlates with higher plasma levels of MCP-1, was associated with prevalent myocardial infarction in a large cohort. 22, 23 C-reactive protein is known to be a risk marker for vascular events, 24 and itself promotes MCP-1-mediated monocyte chemotaxis. 25 As well as adult atherosclerosis, MCP-1 also correlates with acute phase KD vasculitis. 18 , 26 Terai et al 18 have reported profuse extracellular matrix-bound MCP-1 expression on the adventitia and massive mononuclear cell infiltration in a patient who died 14 days after KD onset. In the present study we showed that MCP-1 is still actively involved in late-phase KD; however, little invasion of macrophages or inflammatory mononuclear cells was observed in the present KD aneurysm (data not shown). Lack of macrophage infiltration has been reported by others 11 and is considered a distinct feature of the KD coronary artery lesion compared with atherosclerosis. Therefore, the upregulated MCP-1 in the late-phase KD aneurysm that we observed in the present study is not vascular inflammation persisting from acutephase KD. It may be one of the reactions of vascular senescence. We could not answer why high expression of both MCP-1 and VCAM-1 did not induce infiltration of macrophages or other inflammatory cells into the late-phase KD aneurysm. It may be the relatively short time from the onset of KD. At the very least, together with the finding of vascular senescence, the KD aneurysm is under active remodeling. We can not discard the possibility of early atherosclerosis progression at younger ages, as Takahashi et al reported. 3 We should carefully monitor KD coronary lesions for development into early atherosclerosis or other complicated vascular disease.
On the other hand, physiologically impaired endothelial function in the brachial artery after KD was noted in patients without coronary artery lesions. 2, 27, 28 Those patients had reduced brachial artery flow-mediated dilation (FMD). FMD is dependent on the ability of the endothelium to release nitric oxide. 29 However, another group 30 reported FMD reduction only in cases of KD with moderate to severe CAD, not in those with normal to mild CAD. The issue is still controversial. We used the KD patients' ITA as control tissue and we observed eNOS staining along the intimal endothelium of the ITA. We could not detect further findings of senescence in the ITA. Although KD causes systemic vasculitis, ITA might be affected less by inflammation than either the brachial artery or coronary artery. As the coronary artery is the site of the most severe inflammation in KD, the degree of vasculitis is not homogeneous. Second, what we stained was eNOS antigen. We did not measure eNOS activity itself and this may be reduced in the ITA of KD patients, even though eNOS expression is not impaired. It is conceivable that the ITA are also affected by KD vasculitis to some extent, but not so severe to cause vascular senescence.
For the first time, we report evidence of senescence progression in the KD aneurysm. These histological findings are almost the same as those found in early atherosclerosis in adults. However, there are also histological differences between the KD aneurysm and atherosclerosis. The KD aneurysm is not a terminal phase of vasculitis, but instead is undergoing active vascular remodeling. Vascular senescence of the KD coronary lesion is a risk for future complicated vascular disease, including atherosclerosis, so patients must be carefully followed.
